12:00 AM
May 03, 1999
 |  BC Week In Review  |  Company News  |  Other News

Elan, Warner Chilcott cardiovascular news

ELN reacquired from WCRX all rights to an extended release nifedipine product and the product's filed ANDA. ELN paid a fee and is liable for milestone...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >